UK companies that are struggling and in need of assistance because of due to lockdown rules in the face of the COVID-19 pandemic have several options to choose from, depending on their size and their needs
The US Food and Drug Administration (FDA) has published an announcement of a product recall made voluntarily by a company after tests suggested the CBD oil contained too much lead
Find all of CBD-Intel’s coronavirus-related regulatory alerts here, updated as they appear
A Canadian company part-owned by singer Bif Naked has run foul of Canada’s national health authority after suggesting its CBD products can help protect users from COVID-19
Every state in the US is offering some sort of tax relief in response to the coronavirus pandemic, and many hemp and CBD companies may be eligible for such relief
Initial reports on the results of the first ever socially distanced 4/20 are a mixed bag
While the global coronavirus epidemic and consequent lockdown have caused uncertainty in the cannabis sector, investments in CBD are likely to go ahead in the coming months, some experts in the industry say
As the coronavirus pandemic continues, regardless of location, there is an overwhelming sense of uncertainty in the CBD industry. In this special episode, Tim Phillips – the founder and managing director of CBD-Intel — provides some analysis relating to the three main areas impacted in CBD industry: demand, supply, and regulation; however, he believes that it is too early to discuss the long-term impacts.
Further advances towards the legalisation of cannabis in Mexico have been delayed by a government shutdown due to the COVID-19 pandemic, with a new deadline for legislation set by the country’s Supreme Court
Most US hemp and CBD businesses should qualify for economic relief during the COVID-19 pandemic – but the type of assistance may vary dependent on qualification and availability of funds
CBD companies have had to adapt marketing strategies as the COVID-19 pandemic has developed. The pandemic and the associated practice of social distancing have overtaken 4/20, the biggest promotional day for cannabis
Companies that have made claims about CBD’s beneficial effects against COVID-19 are facing swift enforcement action from US regulatory authorities
CBD entrepreneur Christina DiArcangelo tells CBD-Intel that businesses should be using the slowdown to study, reflect, plan – and “get ahead of the ball”
The wider impact of COVID-19 on the CBD sector in the US remains confused in the short term and largely a mystery in the longer term as companies scramble to gather information
Legislative measures are on hold in half the states of the US due to the COVID-19 emergency, with most suspending activity until at least mid-April
Industry organisations have responded in anger to continued claims being made by some companies about the supposed power of cannabinoids in tackling COVID-19
Also: GW suggests another possible use for Epidyolex; Lawsuit alleges hemp plants were contaminated with pesticide; Elixinol rebrands to move away from medicinal image; Kentucky hemp business goes bust
Expected retail closures will have a significant impact on the distribution of CBD products in most major markets, according to analysis of CBD-Intel data
Bogus claims that products containing CBD may have any beneficial effects in treating or warding off coronavirus risk the wrath of authorities in the US – and could ultimately damage CBD’s reputation
A company has launched a hand sanitiser infused with CBD, a US wellness brand is selling what it claims is the world’s first CBD blanket, and Dog-sledding champion Lance Mackey has admitted to giving his dogs CBD, plus more
As the COVID-19 pandemic continues to affect people across the world, a swathe of CBD-related events have been called off or postponed. Here is a list of some of the major ones, with dates and details
CBD wholesale products pricing report
This report will enable you to identify pricing differences and the range of pricing for product types across different markets, understand possible reasoning for pricing differences across different markets, and identify price points for strategy development and price setting.
Free sample page available
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the CBD-Intel team.
